GlassScriptPhysician profile
Cory Nonnemacher
NPI 1811552649
$3,605.18
in general payments reported to CMS, 2019-2025
25 companies · $35.74 in 2025
The $35.74 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $485 · 2021: $478 · 2022: $903 · 2023: $746 · 2024: $561 · 2025: $35.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,418.86 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acell, INC. | $560.35 | 2019-2020 | |
| Depuy Synthes Sales INC. | $536.32 | 2020-2024 | Matrixrib |
| Aroa Biosurgery Incorporated | $204.21 | 2022-2024 | |
| Kerecis Limited | $130.18 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Csl Behring | $124.75 | 2020-2023 | Kcentra |
| Allergan, INC. | $108.62 | 2020-2022 | |
| Baxter Healthcare | $85.38 | 2019-2023 | Seprafilm, Floseal |
| Avanos Medical | $64.40 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $48.59 | 2023-2024 | Andexxa |
| Chiesi USA, INC. | $40.29 | 2019-2020 | |
| Avita Medical Americas, LLC | $35.74 | 2025 | Recell, Permeaderm, Cohealyx |
| Haemonetics Corporation | $28.20 | 2023 | Teg5000 Hemostasis Analyzer |
| Biocomposites INC | $26.38 | 2023 | Stimulan |
| Janssen Pharmaceuticals, INC | $25.11 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Z-Medica, LLC | $22.32 | 2019 | |
| Btg International INC. | $21.93 | 2022 | |
| Lifenet Health | $20.13 | 2024 | Theragenesis Wound Matrix |
| Innovation Technologies INC | $18.14 | 2023 | Irrisept |
| Zimmer Biomet Holdings, INC. | $18.02 | 2023 | Ribfix Blu Advantage |
| La Jolla Pharmaceutical Company | $16.85 | 2023 | Giapreza |
| W. L. Gore & Associates, INC. | $13.29 | 2021 | |
| Kci USA, INC. | $12.93 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.81 | 2021 | |
| Ethicon US, LLC | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Nonnemacher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.